| scholarly article | Q13442814 |
| P50 | author | Calvin Yu-Chian Chen | Q43177425 |
| P2093 | author name string | Calvin Yu-Chian Chen | |
| P2860 | cites work | Functionality pattern matching as an efficient complementary structure/reaction search tool: an open-source approach | Q84748533 |
| Database resources of the National Center for Biotechnology Information | Q24644775 | ||
| ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
| TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining | Q33375861 | ||
| Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database | Q33525137 | ||
| Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation | Q36054344 | ||
| Structure-based and ligand-based drug design for HER 2 receptor | Q43061745 | ||
| Insights into designing the dual-targeted HER2/HSP90 inhibitors | Q43062815 | ||
| Ligand-based dual target drug design for H1N1: swine flu--a preliminary first study | Q45239894 | ||
| A 3D structure database of components from Chinese traditional medicinal herbs | Q47439107 | ||
| Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5. | Q47442718 | ||
| Traditional Chinese medicine database and application on the Web. | Q47632184 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | in silico | Q192572 |
| database | Q8513 | ||
| traditional Chinese medicine | Q200253 | ||
| drug screening | Q10505555 | ||
| P304 | page(s) | e15939 | |
| P577 | publication date | 2011-01-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico | |
| P478 | volume | 6 |
| Q55530937 | A Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer’s Disease. |
| Q54990524 | A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer. |
| Q36773475 | A Network Pharmacology Approach to Uncover the Pharmacological Mechanism of XuanHuSuo Powder on Osteoarthritis. |
| Q60959778 | A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington's Disease and Validated by Support Vector Machine Model |
| Q57175473 | A New Strategy to Uncover the Anticancer Mechanism of Chinese Compound Formula by Integrating Systems Pharmacology and Bioinformatics |
| Q64274684 | A Novel Discovery: Holistic Efficacy at the Special Organ Level of Pungent Flavored Compounds from Pungent Traditional Chinese Medicine |
| Q44105963 | A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment. |
| Q31021955 | A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Sheng-ma-bie-jia-tang Acting on Systemic Lupus Erythematosus by Multi-Level Data Integration |
| Q64057265 | A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology |
| Q28829710 | A corpus for plant-chemical relationships in the biomedical domain |
| Q36617742 | A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis |
| Q92096755 | A network pharmacology approach to reveal the protective mechanism of Salvia miltiorrhiza-Dalbergia odorifera coupled-herbs on coronary heart disease |
| Q100559769 | A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: an updated prototype in drug discovery |
| Q30841144 | A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases. |
| Q51433900 | A novel algorithm for identification of activated cryptic 5' splice sites. |
| Q47673982 | A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study |
| Q47724399 | A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine |
| Q44999449 | A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors |
| Q114864147 | A primer on natural product-based virtual screening |
| Q55092298 | A strategy to find novel candidate anti-Alzheimer's disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants. |
| Q47431887 | A systems approach to traditional oriental medicine |
| Q28541247 | A systems biology-based approach to uncovering the molecular mechanisms underlying the effects of dragon's blood tablet in colitis, involving the integration of chemical analysis, ADME prediction, and network pharmacology |
| Q36763376 | A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis |
| Q37598989 | A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma |
| Q90405888 | Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study |
| Q46596317 | An efficient computer-aided structural elucidation strategy for mixtures using an iterative dynamic programming algorithm |
| Q45947708 | An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis. |
| Q33876492 | An investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine. |
| Q59791935 | Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms |
| Q46916234 | Antimicrobial peptides in the centipede Scolopendra subspinipes mutilans |
| Q115031291 | Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective |
| Q40155890 | Artificial neural network cascade identifies multi-P450 inhibitors in natural compounds |
| Q90149912 | Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach |
| Q36583396 | BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine |
| Q61813855 | BIOFACQUIM: A Mexican Compound Database of Natural Products |
| Q35071339 | Balancing novelty with confined chemical space in modern drug discovery |
| Q27902287 | BioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts |
| Q47257247 | Biomimetic Sensors for the Senses: Towards Better Understanding of Taste and Odor Sensation |
| Q28077880 | Biomolecular Network-Based Synergistic Drug Combination Discovery |
| Q36232129 | CEMTDD: The database for elucidating the relationships among herbs, compounds, targets and related diseases for Chinese ethnic minority traditional drugs |
| Q57793816 | CMAUP: a database of collective molecular activities of useful plants |
| Q104840023 | COCONUT online: Collection of Open Natural Products database |
| Q37127221 | Cerebrospinal fluid pharmacology: an improved pharmacology approach for chinese herbal medicine research |
| Q46317628 | Cheminformatic characterization of natural products from Panama |
| Q34536422 | Cheminformatics Based Machine Learning Models for AMA1-RON2 Abrogators for Inhibiting Plasmodium falciparum Erythrocyte Invasion |
| Q39424575 | Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective. |
| Q47390143 | Classification of Chinese herbs based on the cluster analysis of delayed luminescence |
| Q91851182 | Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-Shengmai |
| Q37737158 | Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites |
| Q91809305 | Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death |
| Q91867319 | Comparative Network Pharmacology Analysis of Classical TCM Prescriptions for Chronic Liver Disease |
| Q41182142 | Computational Investigation into the Interactions of Traditional Chinese Medicine Molecules of WenQingYin with GluR2 |
| Q57001336 | Computational Methodologies in the Exploration of Marine Natural Product Leads |
| Q33747644 | Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. |
| Q38137563 | Computational methods for drug design and discovery: focus on China |
| Q41875454 | Computer aided screening of potent inhibitor compounds against inhibitor resistant TEM β-lactamase mutants from traditional Chinese medicine |
| Q38580316 | Computer-guided approach to access the anti-influenza activity of licorice constituents |
| Q58860055 | ConMedNP: a natural product library from Central African medicinal plants for drug discovery |
| Q37413030 | Constructing a knowledge-based database for dermatological integrative medical information |
| Q47401521 | Correlation between the different therapeutic properties of Chinese medicinal herbs and delayed luminescence |
| Q38843130 | Counting on natural products for drug design |
| Q35685689 | Current status and prospects of computational resources for natural product dereplication: a review |
| Q30839938 | Data-mining of potential antitubercular activities from molecular ingredients of traditional Chinese medicines |
| Q54240556 | Databases aim to bridge the East-West divide of drug discovery. |
| Q64079790 | Deciphering the Pharmacological Mechanism of the Herb in the Treatment of Nasopharyngeal Carcinoma by Integrating iTRAQ-Coupled 2-D LC-MS/MS Analysis and Network Investigation |
| Q90680295 | Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation |
| Q36123951 | Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach |
| Q33661003 | Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine. |
| Q94327081 | Development of Natural Compound Molecular Fingerprint (NC-MFP) with the Dictionary of Natural Products (DNP) for natural product-based drug development |
| Q43413571 | Discovery of novel insomnia leads from screening traditional Chinese medicine database |
| Q42705819 | Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network. |
| Q45191168 | Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases |
| Q36572904 | Drug design for neuropathic pain regulation from traditional Chinese medicine |
| Q33876519 | Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine. |
| Q36513179 | Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines |
| Q92621396 | ETM-DB: integrated Ethiopian traditional herbal medicine and phytochemicals database |
| Q52647780 | Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation. |
| Q49991525 | Exploring the chemical space of peptides for drug discovery: a focus on linear and cyclic penta-peptides. |
| Q47589131 | Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications |
| Q36933260 | Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications |
| Q33856023 | Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan |
| Q33736326 | Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine |
| Q50745438 | Five-descriptor model to predict the chromatographic sequence of natural compounds. |
| Q42737143 | G.A.M.E.: GPU-accelerated mixture elucidator |
| Q54985486 | GEPSI: A Gene Expression Profile Similarity-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula. |
| Q36644164 | Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes |
| Q28828435 | Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation-immune system imbalance |
| Q44806080 | Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine? |
| Q47626065 | Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point |
| Q55479208 | Hepatoprotective Effect of San-Cao Granule on Con A-Induced Liver Injury in Mice and Mechanisms of Action Exploration. |
| Q97518970 | Hepatoprotective effects of Hovenia dulcis seeds against alcoholic liver injury and related mechanisms investigated via network pharmacology |
| Q28602627 | HerDing: herb recommendation system to treat diseases using genes and chemicals |
| Q30408391 | High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan |
| Q52358295 | IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. |
| Q35652477 | Identification of ALK5 inhibitor via structure-based virtual screening and ADMET prediction |
| Q64062871 | Identification of Chinese Herbal Compounds with Potential as JAK3 Inhibitors |
| Q55207272 | Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches. |
| Q47109280 | Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis |
| Q52725387 | Identification of new inhibitors against human Great wall kinase using in silico approaches. |
| Q40058742 | Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database |
| Q34942905 | Identification of novel compounds against an R294K substitution of influenza A (H7N9) virus using ensemble based drug virtual screening |
| Q38383492 | Identification of novel natural inhibitor for NorM - a multidrug and toxic compound extrusion transporter - an insilico molecular modeling and simulation studies |
| Q28477481 | Identification of potent EGFR inhibitors from TCM Database@Taiwan |
| Q39993258 | Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation |
| Q28478359 | Identifying HER2 inhibitors from natural products database |
| Q28830613 | Identifying enriched drug fragments as possible candidates for metabolic engineering |
| Q97531001 | In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM |
| Q33757779 | In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study |
| Q33678309 | In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease. |
| Q33668052 | In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine. |
| Q33614632 | In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine. |
| Q46550667 | In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease |
| Q55710753 | In Silico Workflow for the Discovery of Natural Products Activating the G Protein-Coupled Bile Acid Receptor 1. |
| Q55343980 | In silico approach in reveal traditional medicine plants pharmacological material basis. |
| Q33668408 | In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes. |
| Q33666808 | In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine. |
| Q88913754 | In silico design of novel proton-pump inhibitors with reduced adverse effects |
| Q36870882 | In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database. |
| Q28483629 | In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine |
| Q28481644 | In silico investigation of potential SRC kinase ligands from traditional Chinese medicine |
| Q33893880 | In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers |
| Q33876312 | In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome |
| Q33895166 | In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers |
| Q33876257 | In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease |
| Q45961735 | In silico pharmacology suggests ginger extracts may reduce stroke risks. |
| Q34156604 | In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date |
| Q58576156 | Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective |
| Q36611260 | Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer |
| Q33862420 | Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine |
| Q34669746 | Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma |
| Q33759927 | Insights into the molecular mechanisms of Polygonum multiflorum Thunb-induced liver injury: a computational systems toxicology approach |
| Q28077746 | Internet Databases of the Properties, Enzymatic Reactions, and Metabolism of Small Molecules-Search Options and Applications in Food Science |
| Q34340279 | Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control |
| Q47278490 | Investigation into potent inflammation inhibitors from traditional Chinese medicine |
| Q33614360 | Investigation of anti-infection mechanism of lactoferricin and splunc-1. |
| Q33903600 | Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine |
| Q33821293 | Investigation of potent lead for acquired immunodeficiency syndrome from traditional Chinese medicine |
| Q30422493 | Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine |
| Q47307503 | Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine |
| Q35137889 | Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders. |
| Q33766033 | Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine |
| Q33615005 | Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine |
| Q30366183 | Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. |
| Q33791008 | Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine |
| Q33810342 | Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine |
| Q53029630 | Ligand binding to anti-cancer target CD44 investigated by molecular simulations. |
| Q33668480 | Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine |
| Q47251605 | Lose weight with traditional chinese medicine? Potential suppression of fat mass and obesity-associated protein |
| Q47782108 | Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression. |
| Q57901103 | Marine Mammals in Asian Societies; Trends in Consumption, Bait, and Traditional Use |
| Q52625121 | Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation. |
| Q45370029 | Memory enhancement by traditional Chinese medicine? |
| Q39432850 | Molecular level activation insights from a NR2A/NR2B agonist |
| Q34365901 | Molecular scaffold analysis of natural products databases in the public domain |
| Q62763486 | NP-Scout: Machine Learning Approach for the Quantification and Visualization of the Natural Product-Likeness of Small Molecules |
| Q47354713 | NP-StructurePredictor: Prediction of Unknown Natural Products in Plant Mixtures |
| Q46268156 | NPASS: natural product activity and species source database for natural product research, discovery and tool development |
| Q92535760 | NaPLeS: a natural products likeness scorer-web application and database |
| Q28727975 | Natural product-likeness score revisited: an open-source, open-data implementation |
| Q38334179 | Natural products as leads in schistosome drug discovery. |
| Q37105281 | Navigating traditional chinese medicine network pharmacology and computational tools |
| Q64119124 | Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment |
| Q92602221 | Network Pharmacology Identifies the Mechanisms of Action of Shaoyao Gancao Decoction in the Treatment of Osteoarthritis |
| Q38510631 | Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products |
| Q43947854 | Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection |
| Q87742410 | Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease |
| Q89553908 | Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment |
| Q38243629 | Network pharmacology: a Rosetta Stone for traditional Chinese medicine |
| Q36900056 | Network pharmacology: a new approach for chinese herbal medicine research |
| Q90382822 | Neuroblastoma SH-SY5Y cytotoxicity, anti-amyloidogenic activity and cyclooxygenase inhibition of Lasianthus trichophlebus (Rubiaceae) |
| Q47259552 | Neuroprotective Potential of Gentongping in Rat Model of Cervical Spondylotic Radiculopathy Targeting PPAR-γ Pathway. |
| Q52809378 | New potential inhibitors of mTOR: a computational investigation integrating molecular docking, virtual screening and molecular dynamics simulation. |
| Q90421142 | Oleanolic Acids Inhibit Vascular Endothelial Growth Factor Receptor 2 Signaling in Endothelial Cells: Implication for Anti-Angiogenic Therapy |
| Q30487721 | Open-access metabolomics databases for natural product research: present capabilities and future potential. |
| Q36036947 | Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway |
| Q39270273 | Personalizing Chinese medicine by integrating molecular features of diseases and herb ingredient information: application to acute myeloid leukemia |
| Q123351378 | PeruNPDB: the Peruvian Natural Products Database for in silico drug screening |
| Q28550827 | PharmDB-K: Integrated Bio-Pharmacological Network Database for Traditional Korean Medicine |
| Q37556518 | Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine |
| Q58802435 | Phenotype-oriented network analysis for discovering pharmacological effects of natural compounds |
| Q36573094 | Physician perceptions of HIV cure in China: A mixed methods review and implications for HIV cure research |
| Q33862690 | Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder |
| Q33608964 | Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer |
| Q33790946 | Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers |
| Q33614602 | Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine |
| Q34022289 | Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer |
| Q47099004 | Predicting new indications of compounds with a network pharmacology approach: Liuwei Dihuang Wan as a case study |
| Q92962871 | Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells |
| Q35628345 | Protective effect of Daming capsule against chronic cerebral ischemia |
| Q44424717 | Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders |
| Q47731882 | Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy |
| Q57814810 | Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease |
| Q58701001 | Rapid screening and identification of bioactive compounds specifically binding to beta 2-adrenoceptor from San-ao decoction using affinity magnetic fine particles coupled with high-performance liquid chromatography-mass spectrometry |
| Q41067321 | Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutants |
| Q34351611 | Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models. |
| Q36855036 | Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation |
| Q38502446 | Review of natural product databases |
| Q104840477 | Review on natural products databases: where to find data in 2020 |
| Q38743935 | Role of Structural Bioinformatics in Drug Discovery by Computational SNP Analysis: Analyzing Variation at the Protein Level |
| Q27902290 | SANCDB: a South African natural compound database |
| Q90559172 | STarFish: A Stacked Ensemble Target Fishing Approach and its Application to Natural Products |
| Q41980724 | Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: identifying DNA repair protein XRCC4 inhibitors |
| Q27144242 | Shifting from the single to the multitarget paradigm in drug discovery |
| Q36027635 | Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases |
| Q47209029 | SistematX, an Online Web-Based Cheminformatics Tool for Data Management of Secondary Metabolites. |
| Q33794802 | Small molecule inhibitors of HCV replication from pomegranate |
| Q89619963 | Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway |
| Q47694026 | Structural insights into impact of Y134F mutation and discovery of novel fungicidal compounds against CYP51 in Puccinia triticina |
| Q64286903 | Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library |
| Q91637842 | Study on the Antibreast Cancer Mechanism and Bioactive Components of Si-Wu-Tang by Cell Type-Specific Molecular Network |
| Q30657668 | Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine |
| Q34047858 | Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study |
| Q34177356 | System analysis of LWDH related genes based on text mining in biological networks |
| Q123350995 | Systematic Description of the Content Variation of Natural Products (NPs): To Prompt the Yield of High-Value NPs and the Discovery of New Therapeutics |
| Q37105102 | Systematic investigation of transcription factors critical in the protection against cerebral ischemia by Danhong injection |
| Q26782866 | Systems Biology - A Pivotal Research Methodology for Understanding the Mechanisms of Traditional Medicine |
| Q92132051 | Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease |
| Q92403114 | Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery |
| Q37708902 | Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes. |
| Q37972867 | Systems biology analysis of protein-drug interactions. |
| Q89251204 | Systems-Based Interactome Analysis for Hematopoiesis Effect of Angelicae sinensis Radix: Regulated Network of Cell Proliferation towards Hemopoiesis |
| Q33767328 | TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations. |
| Q47154424 | TCMID 2.0: a comprehensive resource for TCM. |
| Q36491360 | TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis |
| Q27703005 | TCMSP: a database of systems pharmacology for drug discovery from herbal medicines |
| Q33755425 | TIPdb-3D: the three-dimensional structure database of phytochemicals from Taiwan indigenous plants |
| Q35686675 | TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine |
| Q55270064 | The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach. |
| Q59794299 | The Chinese herbal formula Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice |
| Q92620072 | The Methodological Trends of Traditional Herbal Medicine Employing Network Pharmacology |
| Q38061445 | The application of Chinese medicine to novel drug discovery |
| Q58195302 | The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations |
| Q37602204 | The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds |
| Q33876498 | The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine |
| Q90291678 | The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo |
| Q38637348 | The potential role of in silico approaches to identify novel bioactive molecules from natural resources |
| Q34316470 | Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. |
| Q37588353 | Thyroid hormone synthesis: a potential target of a Chinese herbal formula Haizao Yuhu Decoction acting on iodine-deficient goiter |
| Q37291189 | To Unveil the Molecular Mechanisms of Qi and Blood through Systems Biology-Based Investigation into Si-Jun-Zi-Tang and Si-Wu-Tang formulae |
| Q38059979 | Traditional Chinese herbal medicine as a source of molecules with antiviral activity |
| Q47802856 | Traditional Chinese medicine application in HIV: an in silico study |
| Q47197241 | Traditional Chinese medicine as dual guardians against hypertension and cancer? |
| Q45961690 | Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? |
| Q26778925 | Transcriptomics: a sword to cut the Gordian knot of traditional Chinese medicine |
| Q33746550 | Treatment of acute lymphoblastic leukemia from traditional chinese medicine |
| Q33876600 | Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor |
| Q33786655 | Treatment of rheumatoid arthritis with traditional chinese medicine. |
| Q28478569 | Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine |
| Q38917184 | Ultra high performance liquid chromatography with tandem mass spectrometry for rapid separation and identification of main constituents in Chinese herbal formula Xuan Hu Suo San. |
| Q35227259 | Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation |
| Q49735252 | Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. |
| Q59811770 | Uncovering the mechanism of Maxing Ganshi Decoction on asthma from a systematic perspective: A network pharmacology study |
| Q60916613 | Unveiling Active Constituents and Potential Targets Related to the Hematinic Effect of Steamed Panax notoginseng Using Network Pharmacology Coupled With Multivariate Data Analyses |
| Q28485387 | Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study |
| Q91615235 | Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms |
| Q36393899 | VSPrep: A General KNIME Workflow for the Preparation of Molecules for Virtual Screening |
| Q40116572 | Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach |
| Q42235598 | Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus |
| Q36591830 | Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus |
| Q42214654 | Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase. |
| Q87712669 | WITHDRAWN: DrugPrinter: print any drug instantly |
| Q33631051 | Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation |
| Q42700836 | Xuefu zhuyu decoction improves cognitive impairment in experimental traumatic brain injury via synaptic regulation |
| Q59812347 | YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery |
| Q29615857 | ZINC: a free tool to discover chemistry for biology |
| Q94553756 | ZiYinHuaTan Recipe Inhibits Cell Proliferation and Promotes Apoptosis in Gastric Cancer by Suppressing PI3K/AKT Pathway |
| Q60915719 | eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates |
| Q47287940 | iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design |
| Q47291934 | iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan |
| Q28306830 | istar: a web platform for large-scale protein-ligand docking |
Search more.